Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Germany flag Germany · Delayed Price · Currency is EUR
17.90
0.00 (0.00%)
Last updated: Dec 5, 2025, 8:18 AM CET
-18.64%
Market Cap 649.18M
Revenue (ttm) 628.03M
Net Income (ttm) 38.68M
Shares Out n/a
EPS (ttm) 1.09
PE Ratio 16.78
Forward PE n/a
Dividend 0.47 (2.55%)
Ex-Dividend Date Sep 29, 2025
Volume n/a
Average Volume n/a
Open 17.90
Previous Close 17.90
Day's Range 17.90 - 17.90
52-Week Range 16.20 - 22.40
Beta n/a
RSI 51.10
Earnings Date Feb 6, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p... [Read more]

Industry Pharmaceutical Preparations
Founded 1913
Employees 1,508
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MFY
Full Company Profile

Financial Performance

In 2024, Mochida Pharmaceutical's revenue was 105.16 billion, an increase of 2.21% compared to the previous year's 102.89 billion. Earnings were 5.69 billion, an increase of 25.03%.

Financial numbers in JPY Financial Statements

News

There is no news available yet.